InnoCare Pharma (FRA:33C) Days Payable : 412.04 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is InnoCare Pharma Days Payable?

InnoCare Pharma's average Accounts Payable for the three months ended in Dec. 2023 was €15.98 Mil. InnoCare Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was €3.54 Mil. Hence, InnoCare Pharma's Days Payable for the three months ended in Dec. 2023 was 412.04.

The historical rank and industry rank for InnoCare Pharma's Days Payable or its related term are showing as below:

FRA:33C' s Days Payable Range Over the Past 10 Years
Min: 249.98 Med: 269 Max: 596.83
Current: 596.83

During the past 7 years, InnoCare Pharma's highest Days Payable was 596.83. The lowest was 249.98. And the median was 269.00.

FRA:33C's Days Payable is ranked better than
78.44% of 719 companies
in the Biotechnology industry
Industry Median: 147.29 vs FRA:33C: 596.83

InnoCare Pharma's Days Payable increased from Sep. 2022 (222.99) to Dec. 2023 (412.04). It may suggest that InnoCare Pharma delayed paying its suppliers.

InnoCare Pharma Days Payable Historical Data

The historical data trend for InnoCare Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma Days Payable Chart

InnoCare Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

249.01

261.42

369.37

InnoCare Pharma Quarterly Data
	Dec17	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial												247.78	-	448.49	412.04	509.51

Competitive Comparison of InnoCare Pharma's Days Payable

For the Biotechnology subindustry, InnoCare Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnoCare Pharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InnoCare Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where InnoCare Pharma's Days Payable falls into.

InnoCare Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

InnoCare Pharma's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (16.059	+	17.326)	/	2 )	/	16.495	*	365
=	16.6925					/	16.495	*	365
=	369.37

InnoCare Pharma's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (14.626	+	17.326)	/	2 )	/	3.538	*	365 / 4
=	15.976					/	3.538	*	365 / 4
=	412.04

InnoCare Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCare Pharma (FRA:33C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (FRA:33C) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

09969:Hong Kong 33C:Germany 688428:China

Address

No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206

Website

https://www.innocarepharma.com

InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

InnoCare Pharma (FRA:33C) Headlines

No Headlines